Heather Elizabeth Preston's most recent trade in Aligos Therapeutics Inc was a trade of 5,860 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aligos Therapeutics Inc | Heather Elizabeth Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 5,860 | 5,860 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Heather Elizabeth Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Heather Elizabeth Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Heather Elizabeth Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) |